• Home
• Media Outreach
• Jacobson Pharma Issues Positive Profit Alert

Kamis, 02 Mei 2019 20:30:00

Jacobson Pharma Issues Positive Profit Alert

Expects to Record Over 20% Increase in Profit Attributable to Shareholders

HONG KONG, CHINA - Media OutReach - 2 May 2019 - Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the  "Company"; Stock Code: 2633), a leading company engaging in the research, development, production, marketing and sale of generic drugs and proprietary medicines, has today announced a positive profit alert. Based on a preliminary review on the unaudited consolidated management accounts of the Group for the financial year ended 31 March 2019, the Group is expected to record an increase of over 20% in the consolidated profit attributable to shareholders of the Company as compared with that for the financial year ended 31 March 2018.

The encouraging results were mainly attributable to a steady growth of generic drug business along with the sales revenue generated from newly in-licensed products coupled with an uplifted sales performance on proprietary medicines. Operating leverages and financial savings derived from cost control measures, as well as fair value gain on investment properties of the Group are also expected to contribute to the above-mentioned increase.

Embedding the strategies of regional expansion and targeted portfolio enhancement through in-licensing or products developed in-house, Jacobson Pharma aims to become a leading generic drug and proprietary medicine company in Asia by building a commercially competitive platform in the region.

Backed by a vertically-integrated supply chain and its efficient production facilities as well as a robust in-house research and development pipeline, the Group is among the few with the most extensive sales and distribution coverage in both the private and public sectors in Hong Kong and is poised for a broadened geographic footprint.

Mr. Derek Sum, Chairman and Chief Executive Officer of Jacobson Pharma, said, "The expected increase in earnings of the Company reflects the effectiveness of our across-the-board efforts and demonstrates our capabilities to execute on our growth strategies. From expanding our product portfolios to optimizing the  operating leverage across our production facilities as well as  implementing effective cost controls, our holistic and prudent approach is aimed at facilitating the Group's long-term growth and creating value for our shareholders."

2 minggu lalu

Hitachi Construction Machinery Meluncurkan Kampanye Merek Global Terbaru Menjelang Perubahan Nama Perusahaan dan Merek Menjadi "LANDCROS" pada April 2027

Di saat yang sama, seiring makin beragam dan kompleksnya tantangan yang dihadapi para pelanggan di lokasi kerja mereka, peran yang diharapkan dari kami pun turut berubah secara sig

satu bulan lalu

Kaimirra Opens Boutique at Pavilion Damansara Heights and Kiosk at Pavilion Kuala Lumpur

The Pavilion Damansara Heights boutique held its grand opening on 9 October 2026 with a ribbon-cutting ceremony and lion dance. The kiosk brings the brand to Bukit Bintang, Kuala L

3 bulan lalu

JSCCIB Joins Forces with Public Sector and World Bank to Launch "The Bangkok Business Summit 2026: Reinvent Thailand, Resilient ASEAN"

This event serves as a milestone paving the way toward the IMF-World Bank Group Annual Meetings 2026, which Thailand will proudly host in Bangkok in October 2026, as well as Thaila

3 bulan lalu

Memperluas Cakrawala: Mahasiswa Asal Uzbekistan, Dulatkhan, Meniti Masa Depan di CUHK

Dulatkhan aktif menjalani kehidupan kampus dengan mengikuti kompetisi bola voli antarkolese dan judo, sekaligus menikmati keindahan alam Hong Kong melalui kegiatan mendaki. Semanga